Skip to primary navigation
Skip to main content
Join our community
Login
Enter your search
About
About Lp(a) Forum
Editorial Board
Mission Statement
Back to Basics
What is Lp(a)?
Lp(a) measurement
Why test Lp(a)?
Lp(a) and cardiovascular disease
Lp(a) and current lipid lowering therapies
From the Editors
Expert Commentaries
Expert Views
News
Congress Reports
Journal Updates
Trials
About Trials
Antisense Oligonucleotides
Small Interfering RNAs
Small Molecules
All Trials
Guidelines
Videos
Slides
Resources
Forthcoming Meetings
Key Publications
Links
Lepodisiran
You are here:
Home
> Archives for
Small Interfering RNAs (siRNAs)
> Lepodisiran
Ongoing Trials
A study of lepodisiran (LY3819469) in participants with elevated Lp(a) (NCT055565742)
A study to investigate the effect of lepodisiran on the reduction of major adverse cardiovascular events in adults with elevated lipoprotein(a) (ACCLAIM-Lp(a)) (NCT06292013)
Completed Trials
A study of lepodisiran (LY3819469) in healthy volunteers (NCT04914546)
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
(Founding Partner)